Wells Fargo lowered the firm’s price target on Dentsply Sirona (XRAY) to $19 from $20 and keeps an Equal Weight rating on the shares. The firm notes Q4 fell short of expectations and management remains cautious on the overall macro environment leading to an expected organic sales decline in 2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Hold Rating for DENTSPLY SIRONA Amid Cost-Cutting and Market Challenges
- Dentsply Sirona Faces Challenges with 2024 Earnings
- Morning Movers: Nvidia and Snowflake rise following quarterly earnings releases
- DENTSPLY SIRONA: Overcoming Challenges with Strategic Initiatives and Market Positioning for Long-Term Growth
- Dentsply Sirona sees 2025 adjusted EPS $1.80-$2.00, consensus $1.91